PLATELET P2Y12 INHIBITOR USE AND RISK OF COLORECTAL CANCER AND RELATED DEATH

被引：0
|
作者：
Fuchs, Michael
Ha, Jane
Yan, Jane
Bottai, Matteo
Song, Mingyang
Simon, Tracey G.
Ye, Weimin
Chan, Andrew T.
Ludvigsson, Jonas F.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1148
引用
收藏
页码：S268 / S269
页数：2
相关论文
共 50 条
  • [31] Progress in Platelet Blockers: The Target is the P2Y12 Receptor
    Patel, Prakash A.
    Lane, Bernard
    Augoustides, John G. T.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2013, 27 (03) : 620 - 624
  • [32] DIFFERENTIAL PLATELET ACTIVATION AFTER P2Y12 INHIBITION
    Leunissen, T. C.
    Wisman, P. P.
    van Holten, T.
    de Groot, P.
    Remijn, J.
    Frans, M.
    de Borst, G-J
    Teraa, M.
    Verhaar, M.
    Urbanus, R.
    Roest, M.
    THROMBOSIS RESEARCH, 2016, 141 : S15 - S15
  • [33] Effect of immature platelets on ADP-induced platelet reactivity after infusion of the P2Y12 receptor inhibitor cangrelor and transitioning to oral P2Y12 inhibitors
    Stratz, C.
    Nuhrenberg, T.
    Kleiner, P.
    Leggewie, S.
    Neumann, F. J.
    Hochholzer, W.
    Trenk, D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S23 - S23
  • [34] Canine Cancer Cells Activate Platelets via the Platelet P2Y12 Receptor
    Bulla, Sandra C.
    Badial, Peres R.
    Bulla, Camilo
    JOURNAL OF COMPARATIVE PATHOLOGY, 2022, 192 : 41 - 49
  • [35] P2Y12 inhibitor use predicts hematoma expansion in patients with intracerebral hemorrhage
    Houskamp, Ethan J.
    Liu, Yuzhe
    Silva Pinheiro do Nascimento, Juliana
    Jahromi, Babak S.
    Lindholm, Paul F.
    Kwaan, Hau C.
    Naidech, Andrew M.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (06): : 1535 - 1540
  • [36] The influence of variation in the P2Y12 receptor gene on the magnitude of in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor
    Bouman, H. J.
    van Werkum, J. W.
    Rudez, G.
    Leebeek, F. W. G.
    Kruit, A.
    Hackeng, C. M.
    ten Berg, J. M.
    de Maat, M. P. M.
    Ruven, H. J. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 587 - 588
  • [37] Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor
    Dobesh, Paul P.
    PHARMACOTHERAPY, 2009, 29 (09): : 1089 - 1102
  • [38] REPLY: P2Y12 Inhibitor-Based Monotherapy
    Angiolillo, Dominick J.
    Baber, Usman
    Dangas, George D.
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (10) : 1274 - 1275
  • [39] Attenuation of the P2Y12 Inhibitor Effect with Morphine is likely
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2020, 9 (02)
  • [40] REPLY: Potent P2Y12 Inhibitor Therapy for All?
    Lau, Emily S.
    O'Donoghue, Michelle L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (11) : 1425 - 1426
12345